Henri Leinonen
@Dr_HLeinonen
Followers
102
Following
26
Statuses
72
A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models: https://t.co/6zzSWSaOL6
Kuopio, Suomi
Joined May 2017
RT @FEBSnews: Congratulations to Henri Leinonen of the University of Eastern Finland, Kuopio, Finland, on being awarded a FEBS Excellence A…
0
2
0
0
0
0
RT @Ahmed_B_Mont: Its fascinating to attend #hupo2024, present your work, and interact with proteomics enthusiasts #YPIC #ECR
0
1
0
RT @UniEastFinland: Academy Research Fellow Henri Leinonen at the UEF School of Pharmacy is the 1st Finnish researcher recognised with the…
0
5
0
RT @Ahmed_B_Mont: I am pleased to share our recent publication at @LRLlab and my second postdoctoral publication.
0
2
0
New paper put from our lab! Big congratulations and thanks to first author Dr Ahmed Montaser, et al!
0
0
2
Kivasti typoja sattunut. Englannin kieliset asetukset ja autocorrect… 😃
0
0
0
RT @SethBlackshaw: New study out in @NatureComms identifying new drugs that promote cone photoreceptor viability and function using systems…
0
5
0
RT @NEIDirector: DYK: @NatEyeInstitute seeks to support early-stage clinical trials (e.g., Phase I or II with strong preclinical or prelimi…
0
3
0
Here we present a drug repurposing strategy to treat retinal degenerations. Our treatment slows retinal degeneration in an etiology-independent manner in several distinct disease models. Next milestone: clinical trial in human patients.
1
3
6
First original research article as a lab leader, and the first one from research at @LRLlab! Big thanks to @wipf_group for great collaboration!
Let the light shine on our collaboration with the Leinonen Retina Lab @Dr_HLeinonen @UEF_DrugTech @UniEastFinland ✨ ✨✨✨✨✨✨Synthesis & Biological Analysis of Iso-DMTs in a Model of Light-Induced Retinal Degeneration | ACS MCL
1
1
4
RT @KaikkonenLab: Thrilled to embard on my journey as the director of @AIV_Institute today, embrasing the new challenge with elegance and…
0
3
0
We thank Emil Aaltonen Foundation for the 3-year project grant! Will allow us to dig deeper into the mechanisms of retinal plasticity and investigate its potential role in therapeutic applications.
2
0
10
RT @nymarklab: Successful doctoral defense by Julia Fadjukov with Prof. Christophe Ribelayga as the honored opponent and @IhisTeemu as co-s…
0
4
0